DBV Technologies (DBVT) Revenue Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 12.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.50% |
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 158.77% |
| Jun 30, 2025 | 26.18% |
| Mar 31, 2025 | -43.14% |
| Dec 31, 2024 | -94.24% |
| Sep 30, 2024 | -54.81% |
| Jun 30, 2024 | -49.26% |
| Mar 31, 2024 | -35.87% |
| Dec 31, 2023 | 780.60% |
| Sep 30, 2023 | 14.37% |
| Jun 30, 2023 | 49.64% |
| Mar 31, 2023 | -13.83% |
| Dec 31, 2022 | -144.47% |
| Sep 30, 2022 | 56.76% |
| Jun 30, 2022 | 2.76% |
| Mar 31, 2022 | -13.43% |
| Dec 31, 2021 | 341.91% |
| Sep 30, 2021 | -68.18% |
| Jun 30, 2021 | -58.78% |
| Mar 31, 2021 | -37.69% |
| Sep 30, 2020 | -62.29% |
| Sep 30, 2019 | 218.46% |
| Dec 31, 2015 | 4.52% |
| Jun 30, 2015 | -15.67% |